Cyclosporine Does not Inhibit the Process of Revascularization of Pancreatic Islet Transplantation
The immunosuppressive drug cyclosporin-A (CsA) has been widely used to prevent pancreatic islet allograft rejection. Because it has been suggested that CsA may inhibit the process of revascularization of transplanted islets, the purpose of the study was to analyze by a double indirect immunofluoresc...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
1997-01-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/096368979700600111 |